Deferoxamine - NDC Database

15 records found
Page:1
0409-2336 Apr 30, 2005
Deferoxamine Mesylate 500 mg/1 Intramuscular; Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Hospira, Inc.
0409-2337 Mar 31, 2005
Deferoxamine Mesylate 2 g/1 Intramuscular; Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Hospira, Inc.
0555-1131 May 04, 2004
Deferoxamine Mesylate 2 g/20ml Intramuscular; Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Barr Laboratories Inc.
0555-1132 May 04, 2004
Deferoxamine Mesylate 500 mg/5ml Intramuscular; Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Barr Laboratories Inc.
47781-623 Mar 24, 2018
Deferoxamine Mesylate 500 mg Intramuscular; Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Alvogen Inc.
47781-624 Mar 24, 2018
Deferoxamine Mesylate 2 g/1 Intramuscular; Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Alvogen Inc.
52609-4504 Mar 23, 2018
Deferoxamine Mesylate 2 g/1 Intramuscular; Intravenous Injection, Powder, Lyophilized, for Solution by Apopharma USA, Inc.
52609-4505 Mar 23, 2018
Deferoxamine Mesylate 500 mg Intramuscular; Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Apopharma USA, Inc.
60505-6236 Nov 05, 2021
Deferoxamine Mesylate 500 mg Intramuscular; Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Apotex Corp.
60505-6237 Nov 05, 2021
Deferoxamine Mesylate 2 g/1 Intramuscular; Intravenous Injection, Powder, Lyophilized, for Solution by Apotex Corp.
60505-6238 Mar 28, 2022
Deferoxamine Mesylate 500 mg Intramuscular; Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Apotex Corp.
63323-597 Dec 15, 2009
Deferoxamine 95 mg/ml Intramuscular; Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by App Pharmaceuticals, LLC
63323-599 Dec 15, 2009
Deferoxamine 95 mg/ml Intramuscular; Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by App Pharmaceuticals, LLC
68083-172 Oct 09, 2017
Deferoxamine Mesylate 500 mg Intramuscular; Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Gland Pharma Limited
68083-173 Oct 09, 2017
Deferoxamine Mesylate 2 g/1 Intramuscular; Intravenous Injection, Powder, Lyophilized, for Solution by Gland Pharma Limited
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.